Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion

MLA

Guillaume Schurtz, et al. “Beta-Blocker Management in Patients Admitted for Acute Heart Failure and Reduced Ejection Fraction: A Review and Expert Consensus Opinion.” Frontiers in Cardiovascular Medicine, vol. 10, Nov. 2023. EBSCOhost, https://doi.org/10.3389/fcvm.2023.1263482.

APA

Guillaume Schurtz, Nathan Mewton, Gilles Lemesle, Clément Delmas, Bruno Levy, Etienne Puymirat, Nadia Aissaoui, Fabrice Bauer, Edouard Gerbaud, Patrick Henry, Laurent Bonello, Thomas Bochaton, Eric Bonnefoy, François Roubille, & Nicolas Lamblin. (2023). Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1263482

Chicago

Guillaume Schurtz, Nathan Mewton, Gilles Lemesle, Clément Delmas, Bruno Levy, Etienne Puymirat, Nadia Aissaoui, et al. 2023. “Beta-Blocker Management in Patients Admitted for Acute Heart Failure and Reduced Ejection Fraction: A Review and Expert Consensus Opinion.” Frontiers in Cardiovascular Medicine 10 (November). doi:10.3389/fcvm.2023.1263482.